Meropenem Dosing for Typhoid Fever
For typhoid fever, use meropenem 1 gram IV every 8 hours as a 30-minute infusion in adults with normal renal function, and adjust dosing based on creatinine clearance in patients with renal impairment.
Standard Dosing Regimen
While meropenem is not specifically FDA-approved for typhoid fever, it has demonstrated effectiveness against extensively drug-resistant (XDR) Salmonella typhi infections 1. The FDA-approved dosing for complicated intra-abdominal infections provides the framework:
- Adults with normal renal function: 1 gram IV every 8 hours 2
- Infusion duration: 15-30 minutes (or 3-5 minutes as IV bolus for 1 gram doses) 2
- Pediatric patients ≥3 months: 20 mg/kg every 8 hours (maximum 1 gram per dose) 2
- Infants <3 months: Dosing based on gestational and postnatal age (20-30 mg/kg every 8-12 hours) 2
Renal Dose Adjustments
Dosing must be reduced in renal impairment 2:
- CrCl >50 mL/min: 1 gram every 8 hours (standard dose)
- CrCl 26-50 mL/min: 1 gram every 12 hours
- CrCl 10-25 mL/min: 500 mg every 12 hours
- CrCl <10 mL/min: 500 mg every 24 hours
Calculate creatinine clearance using the Cockcroft-Gault equation when only serum creatinine is available 2.
Special Considerations for Renal Impairment and CRRT
For critically ill patients on continuous renal replacement therapy (CRRT), meropenem clearance is significantly affected 3, 4, 5. Residual diuresis is a critical factor - patients with preserved urine output (>100 mL/24h) require higher doses than oliguric patients 3.
CRRT dosing recommendations 5:
- With residual renal function (CrCl 10-50 mL/min): 0.5 gram every 6 hours or 1 gram every 8 hours as 3-hour infusions
- Anuric patients on CRRT: 500 mg every 8 hours may suffice for susceptible organisms (MIC ≤2 mg/L)
Approximately 25-50% of meropenem is removed by continuous venovenous hemofiltration (CVVHF) and 13-53% by continuous venovenous hemodiafiltration (CVVHDF) 4. For intermittent hemodialysis, administer the dose after dialysis sessions 4.
Clinical Context for Typhoid Fever
Meropenem has proven effective for XDR typhoid fever when first-line agents fail 1. A case report documented successful treatment of typhoid-induced acute liver failure with IV meropenem after ceftriaxone failure 1. The typical treatment duration is 2 weeks 1.
Key clinical pitfalls:
- Typhoid fever can progress rapidly to life-threatening complications including hepatic failure 1
- Blood cultures should always be obtained before initiating therapy 6
- XDR Salmonella typhi is increasingly common, making empiric carbapenem therapy reasonable in severe cases from endemic areas 1, 6
Pharmacokinetic Optimization
For critically ill patients or those with augmented renal clearance (CrCl ≥90 mL/min), standard dosing may be inadequate 7. Extended or continuous infusions improve target attainment 8, 7:
- Continuous infusion of 3-6 grams/day achieves superior PK/PD target attainment (95.3% vs 49.5% for standard infusion) 8
- Patients with augmented renal clearance may require up to 10.5 grams/day by continuous infusion 8
The pharmacodynamic target is maintaining free drug concentrations above the MIC for 40-100% of the dosing interval 3. For resistant organisms (MIC 2-4 mg/L), consider 500 mg every 6 hours as a 3-hour infusion 3.
Therapeutic drug monitoring should be considered in critically ill patients, those with renal dysfunction, or when treating resistant organisms 9.